TAC1, tachykinin precursor 1, 6863

N. diseases: 478; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0010200
Disease: Coughing
Coughing
0.050 Biomarker phenotype BEFREE Patients have an enhanced cough reflex to capsaicin and substance P with respect to control subjects. 30269188 2019
CUI: C0010200
Disease: Coughing
Coughing
0.050 Biomarker phenotype BEFREE Pre-clinical studies suggest that vagal C fibres produce Substance P, one of the tachykinin family of neuropeptides, which has been shown to enhance cough via the neurokinin-1 (NK-1) receptor and studies in animal models have also shown that NK-1 antagonists are effective at blocking induced cough. 31622673 2019
CUI: C0010200
Disease: Coughing
Coughing
0.050 AlteredExpression phenotype BEFREE Before and after treatment, subjective cough measures [visual analog scale (VAS) and the Japanese version of the Leicester Cough Questionnaire (J-LCQ)], the modified frequency scale for the symptoms of GERD [FSSG, consisting of 2 domains: acid-reflux (AR) and functional dyspepsia symptoms], sputum and plasma SP levels, and sputum cell differentials were examined. 31303089 2019
CUI: C0010200
Disease: Coughing
Coughing
0.050 Biomarker phenotype BEFREE The minimum cross-sectional area (p < 0.05), cough count (p < 0.05), and substance P (p < 0.01) improved posttreatment with AzeFlu versus placebo. 28787742 2017
CUI: C0010200
Disease: Coughing
Coughing
0.050 Biomarker phenotype LHGDN Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin. 14564346 2003